CVS Health on Tuesday boosted its earnings guidance for full year 2021, beating analyst expectations.
The pharma company expects adjusted earnings to be in the range of $8.33 to $8.38, up from the previous outlook of at least $8.00. Analyst tracked by FactSet estimate $8.04.
The company continues to guide adjusted earnings in the range of $8.10 to $8.30 for the full year 2022. Analyst expect $8.26.
(ticker: CVS) inched up 1.48% to $106.54 in premarket trading on Tuesday. It rose by over 50% in 2021, while peer
‘s stock (RAD) has fallen 5.8%.
Karen Lynch, CEO of CVS Health, which also owns the health insurer Aetna, will participate at the 40th Annual J.P. Morgan Healthcare Conference today.
Write to Karishma Vanjani at firstname.lastname@example.org